Cargando…

Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure

BACKGROUND: Extracellular vesicle (EV) trafficking is a fundamental cellular process that occurs in cells and is required for different aspects of pathophysiology. EV trafficking leads to changes in cellular function including apoptosis, angiogenesis and proliferation required for increased tumor fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagopoulos, Kiriaki, Cross-Knorr, Sam, Dillard, Christen, Pantazatos, Dionysios, Del Tatto, Michael, Mills, David, Goldstein, Lisa, Renzulli, Joseph, Quesenberry, Peter, Chatterjee, Devasis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851868/
https://www.ncbi.nlm.nih.gov/pubmed/24103426
http://dx.doi.org/10.1186/1476-4598-12-118
_version_ 1782294371020832768
author Panagopoulos, Kiriaki
Cross-Knorr, Sam
Dillard, Christen
Pantazatos, Dionysios
Del Tatto, Michael
Mills, David
Goldstein, Lisa
Renzulli, Joseph
Quesenberry, Peter
Chatterjee, Devasis
author_facet Panagopoulos, Kiriaki
Cross-Knorr, Sam
Dillard, Christen
Pantazatos, Dionysios
Del Tatto, Michael
Mills, David
Goldstein, Lisa
Renzulli, Joseph
Quesenberry, Peter
Chatterjee, Devasis
author_sort Panagopoulos, Kiriaki
collection PubMed
description BACKGROUND: Extracellular vesicle (EV) trafficking is a fundamental cellular process that occurs in cells and is required for different aspects of pathophysiology. EV trafficking leads to changes in cellular function including apoptosis, angiogenesis and proliferation required for increased tumor formation. RESULTS: We report several phenotypic changes mediated by EVs isolated from non-malignant and malignant prostate cells as well as patient biopsied prostate tumor samples. EVs can reverse the resistance of prostate cancer cells to camptothecin EVs isolated from non-malignant PrECs (Prostate Epithelial Cells) can reverse soft agar colony formation of malignant DU145 cells, with the reciprocal effect observed. Isolation of EVs from 2 Gleason grade 8 prostate cancer patients significantly induced soft agar colony formation of non-malignant PrECs. We have identified proteins via antibody and Mass spectrometry analysis that may be responsible for the phenotypic changes. Mass spectrometry analysis of protein lysates using ProteoIQ revealed protein candidates associated with gene ontology annotations that may be responsible for this phenotypic change. Ingenuity Pathway Analysis was used to identify statistically relevant canonical pathways and functions associated the protein IDs and expression values obtained using ProteoIQ. Western blot analysis confirmed the increase of 14-3-3 zeta, pRKIP and prohibitin protein levels in PrEC cells co-cultured with patient EVs. 14-3-3 proteins were also found as common proteins of 3 other Gleason grade 8 patients. CONCLUSION: Our study provides a rational basis to further investigate putative proteins, such as 14-3-3 and prohibitin and genetic factors that may be responsible for phenotypic changes that are associated with prostate cancer progression.
format Online
Article
Text
id pubmed-3851868
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38518682013-12-06 Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure Panagopoulos, Kiriaki Cross-Knorr, Sam Dillard, Christen Pantazatos, Dionysios Del Tatto, Michael Mills, David Goldstein, Lisa Renzulli, Joseph Quesenberry, Peter Chatterjee, Devasis Mol Cancer Research BACKGROUND: Extracellular vesicle (EV) trafficking is a fundamental cellular process that occurs in cells and is required for different aspects of pathophysiology. EV trafficking leads to changes in cellular function including apoptosis, angiogenesis and proliferation required for increased tumor formation. RESULTS: We report several phenotypic changes mediated by EVs isolated from non-malignant and malignant prostate cells as well as patient biopsied prostate tumor samples. EVs can reverse the resistance of prostate cancer cells to camptothecin EVs isolated from non-malignant PrECs (Prostate Epithelial Cells) can reverse soft agar colony formation of malignant DU145 cells, with the reciprocal effect observed. Isolation of EVs from 2 Gleason grade 8 prostate cancer patients significantly induced soft agar colony formation of non-malignant PrECs. We have identified proteins via antibody and Mass spectrometry analysis that may be responsible for the phenotypic changes. Mass spectrometry analysis of protein lysates using ProteoIQ revealed protein candidates associated with gene ontology annotations that may be responsible for this phenotypic change. Ingenuity Pathway Analysis was used to identify statistically relevant canonical pathways and functions associated the protein IDs and expression values obtained using ProteoIQ. Western blot analysis confirmed the increase of 14-3-3 zeta, pRKIP and prohibitin protein levels in PrEC cells co-cultured with patient EVs. 14-3-3 proteins were also found as common proteins of 3 other Gleason grade 8 patients. CONCLUSION: Our study provides a rational basis to further investigate putative proteins, such as 14-3-3 and prohibitin and genetic factors that may be responsible for phenotypic changes that are associated with prostate cancer progression. BioMed Central 2013-10-08 /pmc/articles/PMC3851868/ /pubmed/24103426 http://dx.doi.org/10.1186/1476-4598-12-118 Text en Copyright © 2013 Panagopoulos et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Panagopoulos, Kiriaki
Cross-Knorr, Sam
Dillard, Christen
Pantazatos, Dionysios
Del Tatto, Michael
Mills, David
Goldstein, Lisa
Renzulli, Joseph
Quesenberry, Peter
Chatterjee, Devasis
Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
title Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
title_full Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
title_fullStr Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
title_full_unstemmed Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
title_short Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
title_sort reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851868/
https://www.ncbi.nlm.nih.gov/pubmed/24103426
http://dx.doi.org/10.1186/1476-4598-12-118
work_keys_str_mv AT panagopouloskiriaki reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT crossknorrsam reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT dillardchristen reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT pantazatosdionysios reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT deltattomichael reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT millsdavid reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT goldsteinlisa reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT renzullijoseph reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT quesenberrypeter reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure
AT chatterjeedevasis reversalofchemosensitivityandinductionofcellmalignancyofanonmalignantprostatecancercelllineuponextracellularvesicleexposure